Medicine
The Role of Dietary Anthocyanins for Managing Diabetes Mellitus-Associated Complications
Nov 2025
Article
Source:
Current Diabetes Reviews
21,
e15733998322754
(2025)
Diabetes mellitus (DM) is an intricate metabolic disorder marked by persistent hyperglycemia arising from disruptions in glucose metabolism with two main forms type 1 and type 2 involving distinct etiologies affecting β-cell destruction or insulin levels and sensitivity. The islets of Langerhans particularly β-cells and α-cells play a pivotal role in glucose regulation and both DM types lead to severe complications including retinopathy nephropathy and neuropathy Read More
Diabetes and its Silent Partner: A Critical Review of Hyperinsulinemia and its Complications
Nov 2025
Article
Source:
Current Diabetes Reviews
21,
e15733998311738
(2025)
In this complex realm of diabetes hyperinsulinemia is no longer regarded as just a compensatory response to insulin resistance but rather has evolved into an integral feature. This comprehensive review provides a synthesis of the current literature including various aspects associated with hyperinsulinemia in diabetic complications. Hyperinsulinemia has been shown to be more than just a compensatory mechanism and the key findings demonstrate how Read More
Exploring the Therapeutic Potential of Anti-VEGF Drugs for the Management of Diabetic Retinopathy: An Overview
Nov 2025
Article
Source:
Current Diabetes Reviews
21,
e160424228951
(2025)
The discovery of antivascular endothelial growth factor medications has resulted in a substantial change in diabetic retinopathy treatment. The most common cause of diabetic retinopathy blindness is Diabetic Macular Edema. The pathophysiology of Diabetic Macular Edema is thought to include the well-known pro-angiogenic and pro-permeability factor vascular endothelial growth factor. Over the past decade drugs that impede the functions of va Read More
An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies
Nov 2025
Article
Source:
Current Diabetes Reviews
21,
e240624231266
(2025)
BackgroundDiabetic nephropathy (DN) the primary risk factor for end-stage kidney disease (ESKD) that requires dialysis or renal transplantation affects up to 50% of individuals with diabetes.ObjectiveIn this article potential mechanisms biomarkers and possible therapeutic targets will be discussed as well as their interventional therapies.MethodsA literature review was done from databases like Google Scholar PUBMED-MEDLINE and Scopus using standard k Read More
Impact of SGLT2 Inhibitors on Renal Function in Type 2 Diabetic Patients with Coronary Artery Disease Undergoing Percutaneous Intervention: A Systematic Review and Meta-Analysis
Nov 2025
Article
Source:
Current Diabetes Reviews
21,
e030724231535
(2025)
BackgroundContrast agents directly cause kidney toxicity in patients who are candidates for percutaneous intervention having cardiovascular disease with type 2 diabetes.AimsThis meta-analysis aims to assess the effects of SGLT2i on renal function in individuals undergoing percutaneous intervention.MethodsThe databases used for the search included Google Scholar PubMed Cochrane Central Registry of Controlled Trials and Scopu Read More
The Effect of a Vegan Diet on the Health Indicators and Outcomes of Patients with Type 2 Diabetes Mellitus
Nov 2025
Article
Source:
Current Diabetes Reviews
21,
e020724231487
(2025)
IntroductionRecently there has been a notable increase in interest in various forms of vegetarianism which may be due to the growing prevalence of health issues such as Type 2 Diabetes Mellitus (T2DM). Adhering to a vegan diet may have positive health outcomes. As a result we conducted a review article to gather data from previous research studies on the effects of a vegan diet on different aspects of managing patients with T2DM.MethodsWe search Read More
Integration of Diabetes Mellitus and Hypertension on Major Cardiovascular Events: An Experience From a 15-year Follow-up Cohort Study in EMR
Nov 2025
Article
Source:
Current Diabetes Reviews
21,
e15733998304318
(2025)
IntroductionPatients with hypertension and diabetes are more susceptible to cardiovascular diseases (CVD) and mortality. This study aimed to evaluate the individual and combined effects of hypertension and diabetes on cardiovascular events and mortality in a Middle Eastern population-based cohort.MethodsFifteen-year follow-up data were collected for 6323 adults aged 35 years and older who were free from CVD at baseline. The subje Read More
Cell Therapies and Gene Therapy for Diabetes: Current Progress
Oct 2025
Article
Source:
Current Diabetes Reviews
21,
e130524229899
(2025)
The epidemic of diabetes continues to be an increasing problem and there is a need for new therapeutic strategies. There are several promising drugs and molecules in synthetic medicinal chemistry that are developing for diabetes. In addition to this approach extensive studies with gene and cell therapies are being conducted. Gene therapy is an existing approach in treating several diseases such as cancer autoimmune diseases heart disease and diabet Read More
Molecular Mechanisms Underlying the Therapeutic Potential of Plant-Based α-Amylase Inhibitors for Hyperglycemic Control in Diabetes
Oct 2025
Article
Source:
Current Diabetes Reviews
21,
e020724231486
(2025)
BackgroundDiabetes mellitus (DM) arising from pancreatic β-cell dysfunction and disrupted alpha-amylase secretion manifests as hyperglycemia. Synthetic inhibitors of alpha-amylase like acarbose manage glucose but pose adverse effects prompting interest in plant-derived alternatives rich in antioxidants and anti-inflammatory properties.ObjectiveThe current review investigates plant-based alpha-amylase inhibitors exploring their potential therapeutic r Read More
Therapeutic Interventions for Diabetes Mellitus-associated Complications
Oct 2025
Article
Source:
Current Diabetes Reviews
21,
e030524229631
(2025)
BackgroundDiabetes Mellitus (DM) is an alarming health concern affecting approximately 537 million people worldwide. As a leading cause of morbidity and mortality DM demands a comprehensive understanding of its diverse pathophysiological mechanisms and disease progression.MethodsThis traditional review has consolidated literature on the pathogenesis of hyperglycemia its progression into complications and advances in optimal treatment strategies. Read More
The Multifaceted Role of the Polyphenol Curcumin: A Focus on Type 2 Diabetes Mellitus
Oct 2025
Article
Source:
Current Diabetes Reviews
21,
e15733998313402
(2025)
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by chronic hyperglycemia which often co-exists with other metabolic impairments. This condition can damage various tissues and organs resulting in the development of severe complications both microvascular such as retinopathy nephropathy and neuropathy and macrovascular responsible for an increased risk of cardiovascular diseases. Curcumin is the main bi Read More
A Scoping Review of GIS Mapping of Type 1 Diabetes in Children: Identifying Current Gaps and Future Research Directions Using PRISMA-ScR
Oct 2025
Article
Source:
Current Diabetes Reviews
21,
e260424229413
(2025)
BackgroundType 1 Diabetes poses a significant public health threat especially in low-and-middle countries where resources are limited. The use of geographical information systems in diabetes research has shown the potential to reveal several epidemiological risk factors.AimsThis scoping review aimed to identify the scope and extent of the current literature and explore its limitations on the geographical mapping of children with type 1 diabetes. Read More
Machine Learning and Augmented Intelligence Enables Prognosis of Type 2 Diabetes Prior to Clinical Manifestation
Oct 2025
Article
Source:
Current Diabetes Reviews
21,
e010224226610
(2025)
BackgroundThe global incidence of type 2 diabetes (T2D) persists at epidemic proportions. Early diagnosis and/or preventive efforts are critical to attenuate the multi-systemic clinical manifestation and consequent healthcare burden. Despite enormous strides in the understanding of pathophysiology and on-going therapeutic development effectiveness and access are persistent limitations. Among the greatest challenges the extensive research efforts have n Read More
Comorbidity of Depression and Diabetes: A Literature Review on Systemic Flaws in Healthcare and the Benefits of Collaborative Diagnosis and Treatment in Primary Care Settings
Sep 2025
Article
Source:
Current Diabetes Reviews
21,
E240524230295
(2025)
BackgroundThe increasing specialization and dispersion of healthcare systems have led to a shortage of resources to address comorbidities. Patients with coexisting mental and physical conditions are disadvantaged as medical providers often only focus on the patient's mental illness while neglecting their physical needs resulting in poorer health outcomes.ObjectiveThis study aimed to shed light on the systemic flaws in healthcare systems that contri Read More
Characterization of Green Synthesized Nanoparticles with Anti-diabetic Properties. A Systematic Review
Sep 2025
Article
Source:
Current Diabetes Reviews
21,
E200524230102
(2025)
BackgroundPlants are used in medicine because they are low-cost widely available and have few side effects (compared to pharmacological treatment). Plants have phytocompounds with antidiabetic properties that can be delivered using nanoparticles (NPs).ObjectiveTo describe the antidiabetic properties of green synthesized NPs (GSNPs) and their characterization methods.MethodsThree databases were consulted using the terms “type 2 diabetes mel Read More
An Overview on Diabetic Neuropathy
Sep 2025
Article
Source:
Current Diabetes Reviews
21,
E240624231265
(2025)
The term “Diabetic neuropathy” refers to a collection of clinical and subclinical symptoms caused by problems with the peripheral nervous system. Diabetes which affects approximately 381 million people worldwide is the source of dysfunction due to the emergence of microvascular complications. It is anticipated that in the next ten years Diabetic neuropathy will manifest in about 50% of patients who are currently diagnosed with diabetes. Clinical diagnosis Read More
Correlation between Serum 25 (OH) D Levels with Insulin Resistance and Metabolic Associated Fatty Liver Disease - A Retrospective Study based on Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Sep 2025
Article
Source:
Current Diabetes Reviews
21,
E020724231484
(2025)
AimsThe objective of this study was to investigate the correlation between serum 25 hydroxyvitamin D [25(OH)D] levels and insulin resistance as well as metabolic associated fatty liver disease (MAFLD) in newly diagnosed with type 2 diabetes mellitus (T2DM) patients.MethodsA retrospective analysis was conducted on 491 T2DM patients who were newly diagnosed between January 2017 and August 2022 at Peking University International Hospital. T Read More
In-Vitro and In-Silico Studies of Brevifoliol Ester Analogues against Insulin Resistance Condition
Sep 2025
Article
Source:
Current Diabetes Reviews
21,
E15733998275238
(2025)
BackgroundBrevifoliol is a diterpenoid that occurs naturally in the plants of Taxus genus and is widely used as chemotherapy agent for the management of cancer. A series of semisynthetic esters analogues of brevifoliol were prepared by Steglich esterification and attempted for their pharmacological potential against insulin resistance conditions using in-vitro and in-silico assays.ObjectiveThe aim of this study is to understand the pharmacological potentia Read More
Efficacy of Adjunctive Local Antimicrobials to Non-Surgical Periodontal Therapy in Pocket Reduction and Glycemic Control of Patients with Type 2 Diabetes: A Network Meta-Analysis
Sep 2025
Article
Source:
Current Diabetes Reviews
21,
E15733998320667
(2025)
ObjectiveThis network meta-analysis [NMA] investigated the efficacy of adjunctive use of subgingivally delivered antimicrobials to non-surgical periodontal therapy [NSPT] in the glycemic control and periodontal pocket depth (PPD) reduction in patients with type 2 diabetes (T2D).MethodsSeven databases grey literature and registry platforms were searched up to February 2024 to identify randomized clinical trials (RCT) fulfilling the eligibility criteria. The r Read More
Diabetic Retinopathy-A Review
Sep 2025
Article
Source:
Current Diabetes Reviews
21,
E310524230559
(2025)
Diabetic Retinopathy is a vascular microvascular disease also called diabetic eye disease caused by microangiopathy leading to progressive damage of the retina and blindness. The uncontrolled blood glycemic level or sugar level results in diabetic retinopathy.There are two stages of diabetic retinopathy: proliferative diabetic retinopathy and non-proliferative diabetic retinopathy. Symptoms of diabetic retinopathy often have no early warning signs e Read More
No more items...